JP
John Richard Pinion
See Remarks

John Richard Pinion insider trades: Ultragenyx Pharmaceutical (RARE) stock sales

See Remarks, Ultragenyx Pharmaceutical Last trade Mar 2, 2026 32 Form 4 filings
$229K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2020
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2026RARE↓ Sell$229K
Mar 3, 2025RARE↓ Sell$608K
Mar 1, 2024RARE↓ Sell$224K
May 18, 2023RARE↓ Sell10b5-1$101K
Mar 1, 2023RARE↓ Sell$170K
Mar 1, 2022RARE↓ Sell$300K
Oct 14, 2021RARE↓ Sell$29K
May 6, 2021RARE↓ Sell$41K
Mar 1, 2021RARE↓ Sell$856K
Oct 14, 2020RARE↓ Sell$23K
Oct 12, 2020RARE↓ Sell$263K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RARE insiders

Open-market trades in the last 12 months

About John Richard Pinion's insider trades

John Richard Pinion is See Remarks at Ultragenyx Pharmaceutical (RARE). Since Oct 12, 2020, John has reported no open-market purchases and 11 sales worth $2.8M on SEC Form 4. In the last 12 months: 1 sale ($229K).

1 sale (4% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (16 filings), shares withheld for taxes (16 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RARE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.